JHL Biotech submits application for Bevacizumab Biosimilar
In: BGR India, 2018-04-17
Zeitungsartikel
Zugriff:
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinical Trial Application for a proposed bevacizumab biosimilar, JHL1149, to treat cancer. JHL1149 [...]
Titel: |
JHL Biotech submits application for Bevacizumab Biosimilar
|
---|---|
Zeitschrift: | BGR India, 2018-04-17 |
Veröffentlichung: | 2018 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|